<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>1</Volume><Issue>3</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>09</Month><Day>10</Day></PubDate></Journal><title locale="en_US">Issues Surrounding HIV Status Disclosure: Experiences of Seropositive Women in Lagos, Nigeria</title><FirstPage>1816</FirstPage><LastPage>1816</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Community Health and Primary Care,&#13;
College of Medicine, University of Lagos, PMB 12003, Lagos</affiliation></Author><Author><affiliation locale="en_US">Department of Community Health and Primary Care,&#13;
College of Medicine, University of Lagos, PMB 12003, Lagos</affiliation></Author><Author><affiliation locale="en_US">Department of Community Health and Primary Care,&#13;
College of Medicine, University of Lagos, PMB 12003, Lagos</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>04</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Disclosure of human immunodefciency virus (HIV) seropositivity by infected women is crucial in HIV control. To determine the rates, patterns, effects, and determinants of disclosure of status among HIV‑positive women in Lagos, Nigeria. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This was a descriptive cross‑sectional study. Simple random sampling method was used to select 364 HIV‑positive women accessing&lt;br /&gt;care in HIV treatment centers in Lagos Island. Data were collected using interviewer‑administered questionnaires and analyzed with Epi Info (version 3.5.3). Inferential statistics done was Chi‑square test and level of statistical signifcance was set at &amp;lt;5%.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span class="fontstyle2"&gt; &lt;/span&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Mean age of respondents was 37.3 &amp;plusmn; 3 years, and most were married or cohabiting in monogamous families. The disclosure rates&lt;br /&gt;were 81.9% to anyone (excluding a health care professional); 60.4% to spouse/sexual partners; and 67.7% disclosed on the same day of diagnosis. Main reasons for disclosure were failing health (49.3%) and a sense of responsibility to the spouse/sexual partner (33.6%). Major reasons for nondisclosure were negative public opinion (84.8%) and fear of losing relationships (40.3%). Positive reactions following disclosure were mostly acceptance: 75.2% (family member) and 72.3% (spouse/sexual partner) while blame was the main negative outcome. Longer duration of diagnosis signifcantly improved disclosure to anyone (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001). Older age (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001) and awareness of spouse/sexual partner&amp;rsquo;s HIV status (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001) signifcantly improved disclosure to spouse/sexual partner. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Many respondents had not disclosed their status and require support and counseling to do so. Community education regarding stigmatization should be intensifed.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Human immunodefciency virus disclosure, human immunodefciency virus stigmatization, infectious disease control, Nigeria&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1816</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1816/2105</pdf_url></Article></Articles>
